GPT Pharmaceuticals Private Limited

FDA inspection history in Hyderabad, India, 2019 to 2023

2
Close-outs
2
Form 483s

Every document, by year

  • Close-out
  • Form 483

2019: one close-out letter and one Form 483; 2023: one close-out letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One close-out letter and one Form 483, at Hyderabad, India.
  2. 2019The longest 483 on file: 10 observations over 16 pages at Hyderabad, India.
  3. 2023One close-out letter and one Form 483, at Hyderabad, India.

Cited most

Across all GPT Pharmaceuticals Private Limited observations on file

The complete GPT Pharmaceuticals Private Limited file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Documents

4 on file, newest first
DateDocumentPrice
2023-06-02Close-out Close-out letter$99
2023-01-27483 Form 483$99
2019-12-17Close-out Close-out letter$99
2019-06-28483 Form 483$99

FEI number 3008311641 · most recent document Jun 2, 2023

About GPT Pharmaceuticals Private Limited

How many FDA Form 483s has GPT Pharmaceuticals Private Limited received?

FDA Intel has 2 Form 483s on file for GPT Pharmaceuticals Private Limited; the most recent is dated Jan 27, 2023.

When was GPT Pharmaceuticals Private Limited last inspected by FDA?

The most recent FDA inspection document on file for GPT Pharmaceuticals Private Limited is a Form 483 dated Jan 27, 2023, for the site in Hyderabad, India.

What did FDA cite at GPT Pharmaceuticals Private Limited?

The regulations cited most in the observations on file for GPT Pharmaceuticals Private Limited are 21 CFR 211.22 (Responsibilities of quality control unit), 2 times; 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 2 times; 21 CFR 211.137 (Expiration dating), 1 time.